MDxHealth SA
MDXH
$2.04
$0.073.55%
NASDAQ
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 28.29% | 33.01% | 45.51% | 65.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 28.29% | 33.01% | 45.51% | 65.02% |
| Cost of Revenue | -- | 32.91% | 28.60% | 29.27% | 36.45% |
| Gross Profit | -- | 25.52% | 35.89% | 57.29% | 88.42% |
| SG&A Expenses | -- | 8.87% | 11.60% | 12.32% | 22.14% |
| Depreciation & Amortization | -- | -45.41% | 5.34% | 20.48% | 109.32% |
| Other Operating Expenses | -- | -17.35% | -128.56% | -125.07% | -134.13% |
| Total Operating Expenses | -- | 17.44% | 17.91% | 17.47% | 23.67% |
| Operating Income | -- | 10.42% | 13.77% | 27.99% | 29.28% |
| Income Before Tax | -- | 12.58% | 6.91% | 15.48% | 15.97% |
| Income Tax Expenses | -- | 39,100.00% | 169.53% | 200.00% | -- |
| Earnings from Continuing Operations | -- | 11.67% | 6.40% | 15.48% | 15.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 11.67% | 6.40% | 15.48% | 15.97% |
| EBIT | -- | 10.42% | 13.77% | 27.99% | 29.28% |
| EBITDA | -- | 12.25% | 20.28% | 39.25% | 42.06% |
| EPS Basic | -- | 25.47% | 27.22% | 40.46% | 47.19% |
| Normalized Basic EPS | -- | 35.96% | 65.14% | 78.91% | 78.82% |
| EPS Diluted | -- | 25.47% | 27.22% | 40.46% | 47.19% |
| Normalized Diluted EPS | -- | 35.96% | 65.14% | 78.91% | 78.82% |
| Average Basic Shares Outstanding | -- | 28.65% | 21.32% | 35.16% | 56.16% |
| Average Diluted Shares Outstanding | -- | 28.65% | 21.32% | 35.16% | 56.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |